Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sumatriptan--future development, alternative features and potential new indications].

W S Arnold1

  • 1International Medical Affairs Division, Glaxo Group Research, Greenford, UK.

Neurologia I Neurochirurgia Polska
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibrinolytic and coagulant responses to regional limb perfusions of tumor necrosis factor, interferon-gamma, and/or melphalan.

Thrombosis and haemostasis·1997
Same author

Endogenous D-factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor.

International journal of cancer·1995
Same author

Apparent lymph node primary gastrinoma.

Surgery·1994
Same author

Long term use of sumatriptan.

BMJ (Clinical research ed.)·1994
Same author

Experience with Vi typhoid capsular polysaccharide vaccine in the U.K.

The Journal of infection·1992
Same author

Typhoid Vi: a less reactogenic vaccine.

The Journal of international medical research·1992
Same journal

Highlighting the CSF1R mutational spectrum: c.2549C>T variant in late-onset leukoencephalopathy mimicking multiple sclerosis.

Neurologia i neurochirurgia polska·2026
Same journal

Sacroiliac joint manipulation for low back and radicular pain: outcomes in a 100-patient single-center cohort.

Neurologia i neurochirurgia polska·2026
Same journal

Beyond leukodystrophy: parkinsonism and microglial failure in CSF1R p.Ile794Thr.

Neurologia i neurochirurgia polska·2026
Same journal

Genetic screening for CSF1R variants in patients with dementia, parkinsonism, and multiple sclerosis.

Neurologia i neurochirurgia polska·2026
Same journal

A pilot randomized study of multimodal rehabilitation using a virtual reality-based table tennis program in patients with Parkinson's disease.

Neurologia i neurochirurgia polska·2026
Same journal

Expanding the phenotypic spectrum of RYBP-related neurodevelopmental disorder: report of the ninth patient worldwide.

Neurologia i neurochirurgia polska·2026
See all related articles

Sumatriptan effectively treats acute migraine and cluster headaches. New formulations and routes of administration are being developed to improve patient access and address gastrointestinal issues.

Area of Science:

  • Pharmacology
  • Neurology

Context:

  • Sumatriptan is a selective 5 HT1 receptor agonist used for acute migraine treatment.
  • Migraine and cluster headache patients often experience gastrointestinal symptoms, complicating oral medication.
  • Alternative sumatriptan delivery methods are needed for patients who cannot use oral or subcutaneous forms.

Purpose:

  • To review the efficacy and safety of sumatriptan in acute treatment of migraine and cluster headaches.
  • To explore alternative sumatriptan formulations and routes of administration for improved patient compliance and effectiveness.
  • To investigate new indications for sumatriptan, including menstrual migraine and pediatric migraine.

Summary:

  • Sumatriptan tablets and injections are effective and well-tolerated for acute migraine.

Related Experiment Videos

  • Gastrointestinal symptoms in migraineurs can make oral sumatriptan unsatisfactory.
  • Subcutaneous sumatriptan is effective but not suitable for all patients.
  • Intranasal, rectal, and effervescent tablet formulations are under investigation.
  • Sumatriptan has shown efficacy in treating cluster headaches.
  • New indications, including menstrual and pediatric migraine, are being explored.

    • Impact:

    • Sumatriptan provides effective relief for migraine and cluster headaches.
    • Development of alternative sumatriptan formulations aims to improve treatment accessibility and patient outcomes.
    • Expanding sumatriptan's indications may benefit a wider range of headache sufferers.